Sep 2024

Reckitt Acquires The Sandoz Oral Solid Dosage Manufacturing Facility In Wilson, North Carolina

Reckitt Benckiser Acquisition of the Sandoz Wilson, NC Facility

PharmaBioSource provided exclusive consulting services to Reckitt Benckiser on its acquisition of the Sandoz oral solid dosage manufacturing facility in Wilson, North Carolina.

Service: Consulting
Sector: OTC Products
Subsector: Oral Solid Dosage Manufacturing
Engagement Type: Buy Side

The Wilson facility includes 310,000 SF of oral solid dosage manufacturing, QC laboratories, offices and GMP warehouse space. Reckitt plans on utilizing the facility for the production of oral and liquid form Mucinex and other OTC products. PharmaBioSource’s services included target identification, buy-side data room review, due diligence and negotiations support.

Press Release

Transactions

View All Transactions
Dec 2023

PharmaBioSource Advises Lubrizol on the Sale of Particle Sciences to Agno Pharma

Read More
Nov 2023

Indivior Acquires Sagent Pharmaceutical's Sterile Injectable Fill / Finish Manufacturing Facility in Raleigh, North Carolina

Read More
Jan 2022

Sale of Sterile Fill / Finish & Topical Liquids & Creams Manufacturing & Packaging Facility in New Jersey for $27M

Read More
Jul 2020

Sale of an Oral Solids and Liquids Manufacturing Operation in the U.S.

Read More
Aug 2019

Sale of Soft Gel Development and Manufacturing Assets and Facility Lease

Read More
Jun 2019

Lease of Small Molecule API Research and Development Facility with Kilo Labs and Pilot Plant

Read More
Jun 2019

Divestment of a Small Molecule API Manufacturing Site in Lodi, Italy

Read More
Jun 2019

Divestment of a Sterile Fill / Finish Manufacturing Facility & CMO Business in León, Spain

Read More
Jun 2019

Lease of Cell & Gene Therapy Clinical R&D Laboratories and Manufacturing

Read More